General description
Everolimus (RAD001), a derivative of rapamycin, is commonly used as a drug for the inhibition of the mTOR pathway, affecting tumor cell division and angiogenesis.
Application
Everolimus may be used as a standard in the following clinical studies:
- Investigation of its glucose-dependent growth-inhibitory property in breast cancer cell lines.
- Evaluate its possible antiproliferative effects in human bronchial carcinoids in primary culture.
- UPC:
- 51202603
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- 94687-10MG
